Literature DB >> 30272295

Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.

Young Shin Ko1, Hana Jin1, Jong Sil Lee2, Sang Won Park1, Ki Churl Chang1, Ki Mun Kang3, Bae Kwon Jeong3, Hye Jung Kim1.   

Abstract

Previous studies suggest that cancer stem cells (CSCs) exist in solid tumors, and contribute to therapeutic resistance and disease recurrence. Therefore, the present study aimed to investigate whether radioresistant (RT‑R) breast cancer cells derived from breast cancer cells increase the number of CSCs, and whether these CSCs are responsible to increased invasiveness and therapeutic resistance. MCF‑7, T47D and MDA‑MB‑231 cells were irradiated 25 times (2 Gy each; 50 Gy total) to generate radioresistant breast cancer cells (RT‑R‑MCF‑7, RT‑R‑T47D and RT‑R‑MDA‑MB‑231). RT‑R‑breast cancer cells demonstrated increased cell viability against irradiation and increased colony forming abilities compared with parental breast cancer cells. Particularly, RT‑R‑MDA‑MB‑231 cells derived from highly metastatic MDA‑MB‑231 cells exhibited most radioresistance and chemoresistance of the three cell lines. In addition, MDA‑MB‑231 cells exhibited the most increased protein levels of CSCs markers cluster of differentiation 44, Notch‑4, octamer‑binding transcription factor 3/4 and aldehyde dehydrogenase 1, compared with RT‑R‑MCF‑7 cells, suggesting highly metastatic breast cancer cells MDA‑MB‑231 produce more CSCs. RT‑R‑MDA‑MB‑231 cells increased intercellular adhesion molecule‑1 and vascular cell adhesion molecule‑1 levels, resulting in enhanced migration and adhesion to endothelial cells (ECs), and enhanced invasiveness through ECs by inducing matrix metalloproteinase‑9, Snail‑1 and β‑catenin, and by downregulating E‑cadherin compared with MDA‑MB‑231 cells. These results suggest that highly metastatic breast cancer cells may increase the number of CSCs following radiation therapy, and CSCs present in RT‑R‑MDA‑MB‑231 cells contribute to the enhanced invasiveness by increasing migration, adhesion to ECs and invasion through ECs by promoting epithelial‑mesenchymal transition (EMT) via the upregulation of adhesion molecules and EMT‑associated proteins.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30272295     DOI: 10.3892/or.2018.6714

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  20 in total

1.  Nucleolar localization of the Notch4 intracellular domain underpins its regulation of the cellular response to genotoxic stressors.

Authors:  Neetu Saini; Apurva Sarin
Journal:  Cell Death Discov       Date:  2020-02-18

2.  Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling.

Authors:  Hana Jin; Jong-Sil Lee; Dong-Chul Kim; Young-Shin Ko; Gyeong-Won Lee; Hye-Jung Kim
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

3.  Nucleolar localization of the Notch4 intracellular domain underpins its regulation of the cellular response to genotoxic stressors.

Authors:  Neetu Saini; Apurva Sarin
Journal:  Cell Death Discov       Date:  2020-02-18

4.  Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.

Authors:  Ganiou Assani; Julien Segbo; Xiaoyan Yu; Akadiri Yessoufou; Yudi Xiong; Fuxiang Zhou; Yunfeng Zhou
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

5.  Polyphenols Extracted from Artemisia annua L. Exhibit Anti-Cancer Effects on Radio-Resistant MDA-MB-231 Human Breast Cancer Cells by Suppressing Stem Cell Phenotype, β-Catenin, and MMP-9.

Authors:  Young Shin Ko; Eun Joo Jung; Se-Il Go; Bae Kwon Jeong; Gon Sup Kim; Jin-Myung Jung; Soon Chan Hong; Choong Won Kim; Hye Jung Kim; Won Sup Lee
Journal:  Molecules       Date:  2020-04-21       Impact factor: 4.411

6.  Decitabine Sensitizes the Radioresistant Lung Adenocarcinoma to Pemetrexed Through Upregulation of Folate Receptor Alpha.

Authors:  Yuqing Wang; Jie Huang; Qiong Wu; Jingjing Zhang; Zhiyuan Ma; Lucheng Zhu; Bin Xia; Shenglin Ma; Shirong Zhang
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

7.  miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients.

Authors:  Nesreen G Elhelbawy; Ibrahim F Zaid; Aya A Khalifa; Suzy F Gohar; Eman A Fouda
Journal:  Biochem Biophys Rep       Date:  2021-06-21

8.  Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.

Authors:  Francesco Petragnano; Ilaria Pietrantoni; Simona Camero; Silvia Codenotti; Luisa Milazzo; Francesca Vulcano; Giampiero Macioce; Ilenia Giordani; Paolo Tini; Sara Cheleschi; Giovanni Luca Gravina; Claudio Festuccia; Alessandra Rossetti; Simona Delle Monache; Alessandra Ordinelli; Carmela Ciccarelli; Annunziata Mauro; Barboni Barbara; Cristina Antinozzi; Amalia Schiavetti; Roberto Maggio; Luigi Di Luigi; Antonella Polimeni; Cinzia Marchese; Vincenzo Tombolini; Alessandro Fanzani; Nicola Bernabò; Francesca Megiorni; Francesco Marampon
Journal:  J Biomed Sci       Date:  2020-08-27       Impact factor: 8.410

Review 9.  Oleandrin and Its Derivative Odoroside A, Both Cardiac Glycosides, Exhibit Anticancer Effects by Inhibiting Invasion via Suppressing the STAT-3 Signaling Pathway.

Authors:  Young Shin Ko; Trojan Rugira; Hana Jin; Sang Won Park; Hye Jung Kim
Journal:  Int J Mol Sci       Date:  2018-10-26       Impact factor: 5.923

10.  NLRC4, ASC and Caspase-1 Are Inflammasome Components that Are Mediated by P2Y2R Activation in Breast Cancer Cells.

Authors:  Hana Jin; Hye Jung Kim
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.